Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19
- PMID: 32638079
- PMCID: PMC7340758
- DOI: 10.1007/s00401-020-02190-2
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, Al Rasheed M et al (2020) Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv: 2020.2005.2018.20099960. 10.1101/2020.05.18.20099960
-
- Lorusso R, Gelsomino S, Parise O, Di Mauro M, Barili F, Geskes G, Vizzardi E, Rycus PT, Muellenbach R, Mueller T, et al. Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database. Crit Care Med. 2017;45:1389–1397. doi: 10.1097/ccm.0000000000002502. - DOI - PubMed
-
- Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational research : the journal of laboratory and clinical medicine. 2020;220:1–13. doi: 10.1016/j.trsl.2020.04.007. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
